We are live on ! Find out more
TRVI icon

Trevi Therapeutics
TRVI

18 hedge funds and large institutions have $106M invested in Trevi Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

79.44% more ownership

Funds ownership: 0% → 79.44% (+79%)

Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$54.5M
2
NMC
NEA Management Company
Maryland
+$38.1M
3
OFM
Omega Fund Management
Massachusetts
+$10.9M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.83M
5
Franklin Resources
Franklin Resources
California
+$6.03M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TGHSA
1
TPG Group Holdings (SBS) Advisors
Texas
$47.4M +$54.5M +6,324,319 New
NMC
2
NEA Management Company
Maryland
$33.2M +$38.1M +4,429,804 New
OFM
3
Omega Fund Management
Massachusetts
$9.48M +$10.9M +1,263,408 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.95M +$6.83M +792,700 New
Franklin Resources
5
Franklin Resources
California
$5.25M +$6.03M +700,000 New
SSA
6
Schonfeld Strategic Advisors
New York
$1.76M +$2.02M +234,442 New
DCM
7
Driehaus Capital Management
Illinois
$938K +$1.08M +125,000 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$886K +$1.02M +118,091 New
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$751K +$862K +100,119 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$311K +$357K +41,482 New
Northern Trust
11
Northern Trust
Illinois
$124K +$142K +16,480 New
Millennium Management
12
Millennium Management
New York
$92K +$106K +12,300 New
Morgan Stanley
13
Morgan Stanley
New York
$42K +$48.7K +5,659 New
BlackRock
14
BlackRock
New York
$26K +$30K +3,484 New
UBS Group
15
UBS Group
Switzerland
$14K +$16.5K +1,921 New
TRCT
16
Tower Research Capital (TRC)
New York
$9K +$10.4K +1,202 New
CCA
17
Catalyst Capital Advisors
New York
$6K +$7.32K +850 New
Bank of Montreal
18
Bank of Montreal
Ontario, Canada
$5K +$5.42K +630 New

TRVI Hedge Fund Activity: Q2 2019 in Review

18 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Trevi Therapeutics (TRVI) for Q2 2019, worth a combined $106M.

Buyers outnumbered sellers: 18 funds opened new TRVI positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $54.5M.

  • 18 institutional investors held Trevi Therapeutics (TRVI) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $106M of Trevi Therapeutics stock for Q2 2019.
  • 18 funds opened new Trevi Therapeutics positions in Q2 2019 and 0 closed out, a net change of +18 holders.
  • The largest Trevi Therapeutics buyer in Q2 2019 was TPG Group Holdings (SBS) Advisors, an estimated $54.5M added.

Based on aggregated 13F filings for Q2 2019.